CStone Pharmaceuticals Stock OTC Markets
Stocks
CSPHF
KYG2588M1006
Pharmaceuticals
OTC Markets Traded|
Market Closed -
OTC Markets
19:10:26 30/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.7547 USD | +11.10% |
|
+0.00% | -15.49% |
| 10-09 | GF Securities Starts CStone Pharmaceuticals at Buy with HK$11.56 Price Target | MT |
| 09-24 | CStone Pharma CEO Buys HK$2.7 Million of Shares | MT |
| Market Cap | 6.91B 1.03B 922M 858M 780M 1.47B 99.91B 1.48B 10.32B 4.04B 50.94B 3.88B 3.79B 163B | P/E 2026 * |
-15x | P/E 2027 * | 4.06x |
|---|---|---|---|---|---|
| Enterprise Value | 5.94B 886M 792M 736M 670M 1.26B 85.78B 1.27B 8.86B 3.47B 43.74B 3.33B 3.26B 140B | EV / Sales 2026 * |
14x | EV / Sales 2027 * | 1.68x |
| Free-Float |
79.65% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 2616 | Delayed | |
OTC Markets
| CSPHF | Delayed | |
|
Tradegate
| PH4 | Real-time | |
|
Deutsche Boerse AG
| PH4 | Delayed | |
|
Börse Stuttgart
| PH4 | Delayed | |
|
Boerse Muenchen
| PH4 | Real-time |
Last Transcript: CStone Pharmaceuticals
| 1 day | +11.10% | ||
| 1 week | +0.00% | ||
| Current month | +0.00% | ||
| 1 month | -17.15% | ||
| 3 months | +26.95% | ||
| 6 months | -25.28% | ||
| Current year | -15.49% |
| 1 month | 0.66 |  | 0.75 |
| Current year | 0.59 | | 1.01 |
| 1 year | 0.59 | | 1.01 |
| 3 years | 0.11 | | 1.01 |
| 5 years | 0.11 | | 1.58 |
| 10 years | 0 | | 2.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jian Xin Yang
CEO | Chief Executive Officer | 62 | 25/08/2022 |
Wei Cong Ni
DFI | Director of Finance/CFO | - | 18/01/2023 |
Ying Hua Zhang
COO | Chief Operating Officer | 46 | 01/08/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Wei Li
CHM | Chairman | 55 | - |
Jian Xin Yang
BRD | Director/Board Member | 62 | 25/08/2022 |
Edward Hu
BRD | Director/Board Member | 63 | 09/07/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +11.10% | +0.00% | - | - | 1.03B | |
| +0.83% | +3.19% | +37.87% | +106.25% | 1,051B | |
| +1.93% | +2.11% | +36.82% | +64.90% | 630B | |
| +1.49% | +5.19% | +19.84% | +85.41% | 489B | |
| +2.26% | +0.90% | +66.40% | +39.33% | 359B | |
| +1.45% | +3.50% | +21.87% | +42.64% | 344B | |
| +1.17% | +2.37% | +11.71% | +35.14% | 272B | |
| +0.89% | +1.08% | -7.28% | +10.52% | 246B | |
| +1.82% | +2.94% | +40.43% | +52.78% | 224B | |
| +2.77% | +4.44% | +29.49% | +101.40% | 187B | |
| Average | +2.46% | +2.53% | +28.57% | +59.82% | 422.63B | |
| Weighted average by Cap. | +1.20% | +2.44% | +31.57% | +69.97% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 423M 63.17M 56.42M 52.49M 47.74M 90.14M 6.11B 90.53M 632M 248M 3.12B 237M 232M 10B | 1.72B 257M 230M 214M 194M 367M 24.88B 368M 2.57B 1.01B 12.69B 966M 944M 40.71B |
| Net income | -384M -57.26M -51.14M -47.57M -43.27M -81.7M -5.54B -82.06M -573M -224M -2.83B -215M -210M -9.07B | 680M 102M 90.73M 84.4M 76.77M 145M 9.83B 146M 1.02B 398M 5.01B 381M 373M 16.09B |
| Net Debt | -978M -146M -130M -121M -110M -208M -14.13B -209M -1.46B -572M -7.2B -548M -536M -23.11B | -4.02B -601M -536M -499M -454M -857M -58.12B -861M -6.01B -2.35B -29.63B -2.26B -2.21B -95.1B |
| Date | Price | Change | Volume |
|---|
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 2616 Stock
- CSPHF Stock
Select your edition
All financial news and data tailored to specific country editions
